The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A perspective view of sodium iodide symporter research and its clinical implications
Abstract
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates active iodide transport into the thyroid gland and into several extrathyroidal tissues, in particular the lactating mammary gland. Cloning and molecular characterization of the NIS have allowed the investigation of its key role in thyroid physiology as well as its potential pathophysiological and therapeutic implications in benign and malignant thyroid diseases. Similarly, elucidating the mechanisms underlying the regulation of NIS in lactating mammary gland and breast cancer, in which more than 80% of cases express endogenous NIS, may lead to findings that have novel implications for pathophysiology and therapy. Two approaches may, in the future, pave the way to extend the use of radioiodide treatment to nonthyroidal cancer. One is based on the reinduction of endogenous NIS expression in thyroid and breast cancer by targeting the main mechanisms involving tumoral transformation and dedifferentiation. The other is based on the application of NIS as a novel cytoreductive gene therapy strategy. NIS offers the unique advantage that it can be used both as a reporter and as a therapeutic gene, so that it is possible to image, monitor, and treat the tumor with radioiodide, just as in differentiated thyroid cancer. This review summarizes the main recent findings in NIS research that have a direct impact on diagnosis and therapeutic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Zannini, M., Avantaggiato, V., Biffali, E., Arnone, M. I., Sato, K., Pischetola, M., Taylor, B. A., Phillips, S. J., Simeone, A., & Di Lauro, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3185 · Cited by 259
Regulation of the sodium iodide symporter by iodide in FRTL-5 cells
Eng, P., Cardona, G., Previti, M., Chin, W., & Braverman, L. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440139 · Cited by 100
Cited by
The Na+/I− Symporter (NIS): Mechanism and Medical Impact
Portulano, C., Paroder-Belenitsky, M., & Carrasco, N. (2014) · Endocrine Reviews · doi:10.1210/er.2012-1036 · Cited by 319
Bürgi, H. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.010 · Cited by 249
Zaballos, M. A., Garcia, B., & Santisteban, P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0093 · Cited by 68
Self-citationThe importance of sodium/iodide symporter (NIS) for thyroid cancer management
Carvalho, D. P., & Ferreira, A. C. F. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000500004 · Cited by 53
Wnt-independent role of β-catenin in thyroid cell proliferation and differentiation
Sastre-Perona, A., & Santisteban, P. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1377 · Cited by 43
Self-citation
Metadata
- Authors
- Riesco-Eizaguirre, G., & Santisteban, P.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10
- Volume
- 155
- Issue
- 4
- Pages
- 495-512
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2141753696
- Cited by
- 192
- References
- 3
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A perspective view of sodium iodide symporter research and its clinical implications. https://app.cochat.ai/papers/10.1530/eje.1.02257
- The paper
- Riesco-Eizaguirre, G., & Santisteban, P. (2006). A perspective view of sodium iodide symporter research and its clinical implications. European Journal of Endocrinology. https://doi.org/10.1530/eje.1.02257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.